Measuring severe adverse events and medication selection using a “PEER Report” for nonpsychotic patients: a retrospective chart review

References

• HoffmanDASchillerMGreenblattJMIosifescuDVPolypharmacy or medication washout: an old tool revisitedNeuropsychiatr Dis Treat20117163964822090799
   PubMed Web of Science ®Google Scholar
• WoodsSWMorgensternHSaksaJRIncidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort studyJ Clin Psychiatry201071446347420156410
   PubMed Web of Science ®Google Scholar
• FryeMAKetterTALeverichGSThe increasing use of polypharmacotherapy for refractory mood disorders: 22 years of studyJ Clin Psychiatry200061191510695639
   PubMed Web of Science ®Google Scholar
• MojtabaiROlfsonJNational trends in psychotropic medication polypharmacy in office-based psychiatryArch Gen Psychiatry2010671263620048220
   PubMed Web of Science ®Google Scholar
• HajjarERCafieroACHanlonJTPolypharmacy in elderly patientsAm J Geriatr Pharmacother20075434535118179993
   PubMedGoogle Scholar
• GurvichTCunninghamJAAppropriate use of psychotropic drugs in nursing homesAm Fam Physician20006151437144610735348
   PubMed Web of Science ®Google Scholar
• FeilDWeinrebJSultzerDPsychiatric disorders and psychotropic medication use in elderly persons with diabetesAnn Longterm Care20061473947
   Google Scholar
• Nicole DamestoyNCollinJLalandeRPrescribing psychotropic medication for elderly patients: some physicians’ perspectivesCMAJ1999161214314510439822
   PubMed Web of Science ®Google Scholar
• MontamatSCCusackBOvercoming problems with polypharmacy and drug misuse in the elderlyClin Geriatr Med1992811431581576572
   PubMedGoogle Scholar
• KingsburyLPsychiatric polypharmacy: the good, the bad, and the uglyPsychiatr Times200724413
   Google Scholar
• HelwickCPolypharmacy is common in psychiatry, but is more better?Medscape Medical News972010 Available from: http://www.medscape.com/viewarticle/728132Accessed October 3, 2011
   Google Scholar
• DaoJCareyBFroshDFor some troops, powerful drug cocktails have deadly resultsNew York Times2122011 Available from: http://www.nytimes.com/2011/02/13/us/13drugs.html?ref=benedictcareyAccessed September 16, 2011
   Google Scholar
• MojtabaiROlfsonMNational patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replicationJ Clin Psychiatry20086971064107418399725
   PubMed Web of Science ®Google Scholar
• http://www.nimh.nih.gov [homepage on the Internet]MarylandNational Institute of Mental Health [updated December 14, 2010; cited August 30, 2010]. Available from http://www.nimh.nih.gov/about/director/2010/taking-clinical-research-to-the-next-level.shtml?WT.mc_id=rssAccessed December 22, 2011
   Google Scholar
• InselTCuthbertBGarveryMResearch domain criteria (RDoC): toward a new classification framework for research on mental disordersAm J Psychiatry72010167774875120595427
   PubMed Web of Science ®Google Scholar
• InselTRDisruptive insights in psychiatry: transforming a clinical disciplineJ Clin Invest2008119470070519339761
   PubMed Web of Science ®Google Scholar
• GreenbergGInside the battle to define mental illnessWired12272010 Available from: http://www.wired.com/magazine/2010/12/ffdsmv/all/1Accessed January 20, 2011
   Google Scholar
• RushAJFavaMWisniewskiSRSTAR*D Investigators GroupSequenced treatment alternatives to relieve depression (STAR*D): rationale and designControl Clin Trials200425111914215061154
   PubMedGoogle Scholar
• FavaMRushAJAlpertJEDifference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D reportAm J Psychiatry2008165334235118172020
   PubMed Web of Science ®Google Scholar
• RushAJThe varied clinical presentations of major depressive disorderJ Clin Psychiatry200768Suppl 841017640152
   PubMed Web of Science ®Google Scholar
• HunterAMLeuchterAFMorganMLNeurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placeboNeuropsychophar200530792799
   PubMed Web of Science ®Google Scholar
• IosifescuDVGreenwaldSDevlinPPretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorderActa Psych Scan2008117271276
   PubMed Web of Science ®Google Scholar
• SuffinSCEmoryWHNeurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcomeClin EEG Neurosci1995267683
   Google Scholar
• SchillerMJEmoryWHShafferJEEG guidance of psychopharmacologic treatment: multi-site experience [Poster 10]Proceedings of the 158th Annual Meeting of American Psychiatric AssociationMay 21–26, 2005Atlanta, GA
   Google Scholar
• ShafferJHMilnerJESchillerMJrEEG-Guided Pharmacotherapy for Severely Ill, Dually Diagnosed Patients [Poster 684]Proceedings of the 158th Annual Meeting of American Psychiatric AssociationMay 21–26, 2005Atlanta, GA
   Google Scholar
• SuffinSCEmoryWHGutierrezNA QEEG method for predicting pharmacotherapeutic outcome in refractory major depressive disorderJ Am Phys Surg2007124104108
   Google Scholar
• SchillerMEmoryWHSuffinSCReferenced-EEG in the treatment of eating disorders [Poster 221]Proceedings of the 44th Annual National Institute of Mental Health (NIMH) New Clinical Drug Evaluation Meeting (NCDEU)June 1–4, 2004Phoenix, AZ
   Google Scholar
• DeBattistaCHoffmanDSchillerMIosifescuDReferenced-EEG (rEEG) guidance of medications for treatment resistant depressed patients – a pilot study [Poster 228]Proceedings of the 21st Annual US Psychiatric and Mental Health CongressOctober 30–November 2, 2008San Diego, CA
   Google Scholar
• DebattistaCKinrysGHoffmanDThe use of referenced EEG (rEEG) in assisting medication selection for the treatment of depressionJ Psychiatr Res2011451647520598710
   PubMed Web of Science ®Google Scholar
• GreenblattJMSussmanCJamesonMYuanLHoffmanDAIosifescuDVRetrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disordersNeuropsychiatr Dis Treat20117152954121931495
   PubMed Web of Science ®Google Scholar
• GuyWECDEU Assessment Manual for Psychopharmacology – Revised (DHEW Publ No ADM 76-338)Rockville, MDUS Department of Health, Education, and Welfare; Public Health Service; Alcohol, Drug Abuse, and Mental Health Administration; NIMH Psychopharmacology Research Branch; Division of Extramural Research Programs1976218222
   Google Scholar
• GuyWClinical Global Impressions (CGI) Scale Modified from: Rush J, et al Psychiatric MeasuresWashington, DCAPA2000
   Google Scholar
• EndicottJNeeJHarrisonWBlumenthalRQuality of life enjoyment and statistical questionnaire: a new measurePsychopharacol Bull1993292321326
   PubMed Web of Science ®Google Scholar
• SchechterDEndicottJNeeJQuality of life of normal controls: association with lifetime history of mental illnessPsychiatry Res20071521455410.1016/j.psychres.2006.09.00817363070
   PubMed Web of Science ®Google Scholar
• ChandPKMattooSKSharanPQuality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxisPsychiatry Clin Neurosci200458331131815149299
   PubMed Web of Science ®Google Scholar
• KocsisJHZisookSDavidsonJDouble-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomesAm J Psychiatry199715433903959054788
   PubMed Web of Science ®Google Scholar
• PollackMHOttoMWWorthingtonJJManfroGGWolkowRSertraline in the treatment of panic disorder: a flexible-dose multicenter trialArch Gen Psychiatry19985511101010169819070
   PubMed Web of Science ®Google Scholar
• LiebowitzMRDeMartinisNAWeihsKEfficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled studyJ Clin Psychiatry200364778579212934979
   PubMed Web of Science ®Google Scholar
• ZisookSTrivediMHWardenDClinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D studyJ Affect Disord920091171–2637319217668
   PubMed Web of Science ®Google Scholar
• WardenDRushAJWisniewskiSRWhat predicts attrition in second step medication treatments for depression?: a STAR*D ReportInt J Neuropsychopharmacol200912445947318611293
   PubMed Web of Science ®Google Scholar
• RadleyDCFinkelstienSNStaffordRSOff-label prescribing among office-based physiciansArch Intern Med20061661021102616682577
   PubMed Web of Science ®Google Scholar
• YuryCFisherJValensteinMMatuszakJMeta-analysis of antidepressant augmentation piling on in the absence of evidenceEthical Hum Psychol and Psychiatry2009113
   Google Scholar
• WaltonSMSchumockGTLeeK-VDeveloping evidence-based research priorities for off-label drug useEffective Health Care Research Report 12 (Prepared by the University of Illinois at Chicago DEcIDE Center Under Contract No HHSA29020050038I T03)Rockville, MDAgency for Healthcare Research and Quality2009
   Google Scholar
• MaglioneMRuelazMaherAHuJOff-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43. (Prepared by the Southern California/RAND Evidence-based Practice Center under Contract No. HH54290-2007-10062-1.)AHRQ Publication No. 11-EHC087-EFRockville, MDAgency for Healthcare Research and Quality92011 Available from: www.effectivehealthcare.ahrq.gov/reports/finalcfmAccessed January 20, 2011
   Google Scholar